258 related articles for article (PubMed ID: 32563178)
1. Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden.
Skarping I; Förnvik D; Heide-Jørgensen U; Sartor H; Hall P; Zackrisson S; Borgquist S
Breast; 2020 Oct; 53():33-41. PubMed ID: 32563178
[TBL] [Abstract][Full Text] [Related]
2. Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients.
Skarping I; Förnvik D; Heide-Jørgensen U; Sartor H; Hall P; Zackrisson S; Borgquist S
Cancer Causes Control; 2021 Mar; 32(3):251-260. PubMed ID: 33377172
[TBL] [Abstract][Full Text] [Related]
3. Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer.
Skarping I; Förnvik D; Sartor H; Heide-Jørgensen U; Zackrisson S; Borgquist S
BMC Cancer; 2019 Dec; 19(1):1272. PubMed ID: 31888552
[TBL] [Abstract][Full Text] [Related]
4. The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy.
Cullinane C; Brien AO; Shrestha A; Hanlon EO; Walshe J; Geraghty J; Evoy D; McCartan D; McDermott E; Prichard R
Breast Cancer Res Treat; 2022 Jul; 194(2):385-392. PubMed ID: 35606616
[TBL] [Abstract][Full Text] [Related]
5. Mammographic density to predict response to neoadjuvant systemic breast cancer therapy.
Di Cosimo S; Depretto C; Miceli R; Baili P; Ljevar S; Sant M; Cappelletti V; Folli S; Gennaro M; De Braud FG; Bianchi G; Vingiani A; Pruneri G; Marchianò A; La Rocca E; De Santis MC; Scaperrotta GP
J Cancer Res Clin Oncol; 2022 Apr; 148(4):775-781. PubMed ID: 35037102
[TBL] [Abstract][Full Text] [Related]
6. Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.
Skarping I; Förnvik D; Zackrisson S; Borgquist S; Rydén L
Breast Cancer Res Treat; 2021 Aug; 189(1):131-144. PubMed ID: 34120224
[TBL] [Abstract][Full Text] [Related]
7. Mammographic density in relation to breast cancer recurrence and survival in women receiving neoadjuvant chemotherapy.
Zdanowski A; Sartor H; Feldt M; Skarping I
Front Oncol; 2023; 13():1177310. PubMed ID: 37388229
[TBL] [Abstract][Full Text] [Related]
8. Breast Density Estimation with Fully Automated Volumetric Method: Comparison to Radiologists' Assessment by BI-RADS Categories.
Singh T; Sharma M; Singla V; Khandelwal N
Acad Radiol; 2016 Jan; 23(1):78-83. PubMed ID: 26521687
[TBL] [Abstract][Full Text] [Related]
9. Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer.
Ahn JH; Go J; Lee SJ; Kim JY; Park HS; Kim SI; Park BW; Park VY; Yoon JH; Kim MJ; Park S
Korean J Radiol; 2023 May; 24(5):384-394. PubMed ID: 37133209
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Visual Assessment of Breast Density in BI-RADS 4th and 5th Editions With Automated Volumetric Measurement.
Youk JH; Kim SJ; Son EJ; Gweon HM; Kim JA
AJR Am J Roentgenol; 2017 Sep; 209(3):703-708. PubMed ID: 28657850
[TBL] [Abstract][Full Text] [Related]
11. Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk.
Hudson S; Vik Hjerkind K; Vinnicombe S; Allen S; Trewin C; Ursin G; Dos-Santos-Silva I; De Stavola BL
Breast Cancer Res; 2018 Dec; 20(1):156. PubMed ID: 30594212
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.
Jeffers AM; Sieh W; Lipson JA; Rothstein JH; McGuire V; Whittemore AS; Rubin DL
Radiology; 2017 Feb; 282(2):348-355. PubMed ID: 27598536
[TBL] [Abstract][Full Text] [Related]
13. Fully automated measurements of volumetric breast density adapted for BIRADS 5th edition: a comparison with visual assessment.
Youk JH; Gweon HM; Son EJ; Eun NL; Kim JA
Acta Radiol; 2021 Sep; 62(9):1148-1154. PubMed ID: 32910685
[TBL] [Abstract][Full Text] [Related]
14. Measuring mammographic density: comparing a fully automated volumetric assessment versus European radiologists' qualitative classification.
Sartor H; Lång K; Rosso A; Borgquist S; Zackrisson S; Timberg P
Eur Radiol; 2016 Dec; 26(12):4354-4360. PubMed ID: 27011371
[TBL] [Abstract][Full Text] [Related]
15. Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study.
Kerlikowske K; Scott CG; Mahmoudzadeh AP; Ma L; Winham S; Jensen MR; Wu FF; Malkov S; Pankratz VS; Cummings SR; Shepherd JA; Brandt KR; Miglioretti DL; Vachon CM
Ann Intern Med; 2018 Jun; 168(11):757-765. PubMed ID: 29710124
[TBL] [Abstract][Full Text] [Related]
16. Association of area- and volumetric-mammographic density and breast cancer risk in women of Asian descent: a case control study.
Mariapun S; Ho WK; Eriksson M; Mohd Taib NA; Yip CH; Rahmat K; Hall P; Teo SH
Breast Cancer Res; 2024 May; 26(1):79. PubMed ID: 38750574
[TBL] [Abstract][Full Text] [Related]
17. Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women.
Han Y; Moore JX; Colditz GA; Toriola AT
JAMA Netw Open; 2022 Feb; 5(2):e2148983. PubMed ID: 35175341
[TBL] [Abstract][Full Text] [Related]
18. Functional hemodynamic imaging markers for the prediction of pathological outcomes in breast cancer patients treated with neoadjuvant chemotherapy.
Deng B; Muldoon A; Cormier J; Mercaldo ND; Niehoff E; Moffett N; Saksena MA; Isakoff SJ; Carp SA
J Biomed Opt; 2024 Jun; 29(6):066001. PubMed ID: 38737790
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of assigned BI-RADS breast density category definitions.
Nicholson BT; LoRusso AP; Smolkin M; Bovbjerg VE; Petroni GR; Harvey JA
Acad Radiol; 2006 Sep; 13(9):1143-9. PubMed ID: 16935726
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
